Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int Immunopharmacol ; 134: 112250, 2024 Jun 15.
Article in English | MEDLINE | ID: mdl-38749335

ABSTRACT

Trypanosoma brucei, a causative agent of human and animal trypanosomiasis, regularly switches its major surface antigen to avoid elimination by the immune system. Toll-like receptor 9 (TLR9) is a key modulator for resistance to host-infective trypanosomes; however, the underlying molecular mechanism remains indistinct. Thus, we first approached the issue using Tlr9-mutant mice that render them non-responsive to TLR9 agonists. After infection, T cells in the spleens of Tlr9-mutant mice were analyzed by flow cytometry and a reduction in CD8+, CD4+ T, and NKT cells was observed in Tlr9-mutant mice compared to WT mice. We further found that the responses of inflammatory cytokines in the sera were reduced in Tlr9-mutant mice after T. brucei infection. The underlying molecular mechanism was that T. b. brucei DNA activated TLR9, which consequently upregulated the expression of p38 and ERK/MAPK, resulting in host resistance to trypanosome infection. In conclusion, these findings provide novel insights into the TLR9-mediated host responses to trypanosome infection.


Subject(s)
Cytokines , Signal Transduction , Toll-Like Receptor 9 , Trypanosoma brucei brucei , Trypanosomiasis, African , Toll-Like Receptor 9/metabolism , Toll-Like Receptor 9/agonists , Animals , Trypanosoma brucei brucei/immunology , Trypanosomiasis, African/immunology , Mice , Cytokines/metabolism , Mice, Knockout , Mice, Inbred C57BL , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...